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Abstract
Objective: To identify and analyse topical treatments for peripheral venous catheter 
(PVC)- related phlebitis.
Design: The methodological framework used to make this scoping review was de-
veloped by Arksey and O'Malley (2005; (International Journal of Social Research 
Methodology, 8, 2005 and 19)).
Data sources: A literature search was performed in various databases such as PubMed, 
Scopus, CINAHL, Cochrane, Cuiden, Web of Science, WorldWideScience and Joanna 
Briggs. Additionally, articles from informal sources were incorporated.
Review methods: A search and selection were made of experimental, quasi- 
experimental and pre- experimental studies published between January 2015 and 
September 2020 that consider the use of topical products for the treatment of hos-
pital in- patients with PVC- related phlebitis. Appraisal of the methodological quality 
of the study was performed independently by pairs of reviewers on the basis of the 
Cochrane Collaboration tool. The review was based on the guidelines in the PRISMA- 
ScR statement.
Results: Twenty- two articles were selected (8 randomised controlled trials (RCTs), 12 
quasi- RCTs and 2 pre- experimental studies) which considered treatments applied to 
a total of 2042 adult patients. The topical treatments described were classified into 
physical measures and phytotherapeutic and pharmacological treatments. The physi-
cal measures are easy to apply, but their effectiveness is limited. The main limitation 
of the phytotherapeutic treatments is their marketing and use in eastern culture. The 
best performing pharmacological treatment is the application of magnesium sulphate 
either with or without glycerine. These products can be presented in different phar-
maceutical formulas: ointment, solution and oil.
Conclusions and relevance to clinical practice: The evidence currently available on 
this issue is limited and often of dubious methodological rigour. Further studies are 
required on the treatment and follow- up of intravenous therapy- related phlebitis in 
different national and international contexts.
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1  |  INTRODUC TION
Phlebitis or thrombophlebitis is a frequent complication of intrave-
nous catheters inserted into peripheral veins (Di Nisio et al., 2015). 
The resulting inflammation may be due to mechanical, chemical or 
bacterial factors (Higginson & Parry, 2011; Urbanetto et al., 2017). 
Symptoms include erythema, warmth, swelling and the formation of 
fibrous cords that are palpable along the venous passageway (Dos 
Reis et al., 2009; Webster et al., 2015). A meta- analysis found no 
statistically significant correlations between the occurrence of phle-
bitis and catheter gauge, insertion site or the duration of the cath-
eterisation (Chang & Peng, 2018). Phlebitis may present while the 
peripheral venous catheter (PVC) is in situ and up to 96 h after its 
removal. However, it is normally detected during the first 24– 72 h 
(Urbanetto et al., 2017).
The wide disparity (from 0% to 80%) in the reported incidence 
rate of phlebitis (Di Nisio et al., 2015; Ray- Barruel et al., 2014) is 
attributable to the lack of consensus on its assessment (Mihala et al., 
2018; Webster et al., 2015). As well as its clinical significance, var-
ious studies (Nassaji- Zavareh & Ghorbani, 2007; Urbanetto et al., 
2017) have shown that phlebitis entails additional economic costs 
for the healthcare system and longer hospital stays, and may lead to 
more serious medical complications.
With respect to the treatment to be applied, there is general 
agreement that the first step should be to immediately interrupt the 
infusion and remove the PVC (Webster et al., 2015). Systemic and 
topical treatments are available, with the latter the most commonly 
used to control symptoms and alleviate patient discomfort (Di Nisio 
et al., 2015; Lian et al., 2017). However, there is a lack of consen-
sus on topical interventions, with only two systematic reviews con-
ducted on this topic (Goulart et al., 2020; Martín Gil et al., 2017). 
The study by Martín Gil et al. (2017) reported on the pharmacolog-
ical (heparinoids, diclofenac, nitroglycerine) and phytotherapeutic 
products (chamomile, notoginseny, aloe vera) used in the treatment 
of phlebitis. Other products analysed in the study by Goulart et al. 
(2020) included sesame and rosemary, although it should be noted 
that the study considered topical interventions for both the treat-
ment and prevention of PVC- related phlebitis. It should also be 
noted that some of the studies included in these reviews are rela-
tively old (1998, 1999 or 2000) and that the focus of the analysis 
was centred on the products. The products that are available and 
effective need to be included in the treatment protocols for PVC- 
related phlebitis that are urgently required by nursing professionals 
to help in the clinical decision- making process.
This present review is therefore complementary to the previous 
reviews that have been performed and its objectives are: (1) to fur-
ther the understanding and knowledge about the treatment of phle-
bitis for the reasons set out (high incidence, economic cost, patient 
discomfort and possible complications); (2) to update the analysis 
of PVC- related phlebitis in accordance with recently published ev-
idence; and (3) to undertake an in- depth analysis of the proposed 
therapies, especially in relation to the products and the way they 
are administered.
2  |  AIMS
This scoping review aims to identify and analyse topical treatments 
for PVC- related phlebitis.
3  |  METHODS
A scoping review entails a systematic ‘mapping’ of the literature and 
scientific evidence with a view to summarising the research results 
on a specific topic (Arksey & O'Malley, 2005). The present scoping 
review follows the methodological approach of Arksey and O'Malley 
(2005). The process is divided into 5 stages. Moreover, in order 
to develop a greater understanding of relevant terminology, core 
K E Y W O R D S
intravenous infusion, peripheral venous catheter, phlebitis, therapeutic, topical treatment
What does this paper contribute to the wider 
global clinical community?
• The medical approach to PVC- related phlebitis remains 
an unresolved clinical issue which has a direct impact 
on patient healthcare quality and safety as well as an 
economical impact on the health system.
• The present review shows that el magnesium sulphate 
either with or without glycerine is postulated as the 
most effective treatment. However, this result is not de-
finitive. The results of this scoping currently available in 
the literature are predominantly of Asian origin. Some 
of these studies use products that are not marketed in a 
Western sanitary context. That is why research in other 
regions of the world is urgently required in order to form 
a consensus and facilitate contextual adaptation of the 
therapies to be applied.
• Such new research should focus not only on the prod-
ucts themselves but also consider administrative as-
pects and interventions to enable a better comparison 
of studies and avoid the present high degree of hetero-
geneity. The results would help all nurses in their clinical 
practice worldwide to standardise care plans and really 
base the cure for PVC- related phlebitis on evidence.
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concepts and key items to report for this scoping review, Preferred 
Reporting Items for Systematic reviews and Meta- Analyses exten-
sion for Scoping Reviews (PRISMA- ScR) was used (Appendix S1).
3.1  |  Stage 1: identifying the research question
The research questions identified in stage 1 and used as the basis for 
the search strategies are as follows:
1. What topical treatments are used to tackle the problem of 
PVC- related phlebitis in adult hospital in- patients?
2. How are these treatments applied?
3. According to the results obtained, are the products and the means 
of administration of these treatments effective?
3.2  |  Stage 2: identifying relevant studies
Identification of the studies was undertaken through a system-
atic electronic database search of PubMed, Scopus, Cochrane 
Library, CINAHL, Cuiden, Web of Science, WorldWideScience and 
Joanna Briggs. Articles identified through other sources such as 
ScienceDirect, Google Scholar, ProQuest Dissertations and Theses 
Global, were also incorporated. In order to reduce publication bias, ar-
ticles from informal sources were additionally included. Appropriate 
keywords were selected using MeSH or free descriptors: ‘Phlebiti*’, 
‘Periphlebiti*’, ‘Thrombophlebiti*’, ‘Catheterization, Peripheral’, 
‘Infusions, Intravenous’, ‘Intravenous Infusion*’, ‘Intravenous drip’, 
‘Administration, Topical’, ‘Administration, Cutaneous’, ‘Therap*’, 
‘Treatment*’.
Articles included in this scoping review met the following spec-
ified inclusion criteria: (1) randomised controlled trial (RCT), quasi- 
experimental (quasi- RCT) or pre- experimental designs; (2) adult 
hospital in- patients who had undergone PVC insertion, been diag-
nosed with any grade of upper limb phlebitis during their hospital 
stay and been treated with a topical therapy; (3) published in English 
or Spanish; and (4) published between January 2015 and September 
2020. Papers which included patients with other venous catheters, 
or which focused exclusively on paediatric populations, phlebitis 
prevention treatments and patients with bacterial and bloodstream 
phlebitis were excluded.
3.3  |  Stage 3: study selection
The first step in the study selection process was to import all the 
database search results into Mendeley, version 1.19.3 (https://www.
mende ley.com) and screen for duplicates. The study selection pro-
cess was exported to a database manager generated by the authors 
of the present study in Excel (version 16.16.6). Two review authors 
(JG, OM) independently screened the titles and abstracts of the 
identified references and eliminated any irrelevant studies.
In step 2, the full text of the remaining studies was obtained and 
screened independently by two review authors (JG, OM) with a third 
(JR) resolving any disputes. Studies ranked as irrelevant by both re-
viewers were excluded. The research team maintained continuous 
contact, following an iterative process for the search strategy, and 
the selection and inclusion of the articles.
3.4  |  Stage 4: charting the data
Following initial screening, two reviewers (OM, JR) extracted four 
specific components using a standardised form: (1) General data 
(author(s), year of publication, country); (2) Methodological ele-
ments (design, sample); (3) Data of the intervention (setting, product, 
phlebitis evaluation, form of administration); and (4) data evaluating 
treatment efficacy (results/outcomes measures).
Additionally, even though it is not mandatory to assess the meth-
odological quality in a scoping review (Arksey and O'Malley, 2005), 
this was performed using the Cochrane Collaboration tool described 
in the Cochrane Handbook for Systematic Reviews of Interventions 
(Higgins et al., 2019). Two reviewers (JR and JG) independently 
evaluated the quality of the included studies and the results were 
compared for precision and consistency, while OM resolved any 
discrepancies.
3.5  |  Stage 5: collating, summarising and 
reporting the results
The interventions were classified according to the nature of the 
treatments (pharmacological, phytotherapeutic and/or physical 
measures), the pharmacological presentation, the mode of applica-
tion and their effect in relation to the regression of the degree of 
phlebitis or of the signs or symptoms associated with it.
4  |  RESULTS
4.1  |  Identification and selection of relevant papers
A total of 147 references were identified through the various data-
base search strategies. A manual and grey literature search identi-
fied a further 121 studies, making a total of 268 records.
After eliminating duplicates (n = 45), an initial screening of the 
remaining potentially eligible articles (n = 223) was performed on 
the basis of their titles and abstracts. The full text of the remaining 
articles (n = 28) was subsequently analysed, and those that did not 
meet the inclusion criteria were excluded. The final total of articles 
included in this review was 22. The process that was followed is 
shown in the PRISMA flow diagram below (Figure 1).
The degree of agreement between study evaluations was mea-
sured using the Kappa Index, giving a result of 0.812 (indicating very 
good agreement).
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4.2  |  Characteristics of included studies
The relevant characteristics of the studies included are summarised 
in Table 1. By design, of the total of 22 selected studies 8 were RCTs, 
12 quasi- RCTs and 2 pre- experimental. These were carried out in 
India (n = 16), China (n = 1), Indonesia (n = 1), Nepal (n = 1) and Iran 
(n = 3).
The total number of patients included in the studies was 2042, 
ranging in age from 17 to 70 except in the studies by Ravindra and 
Patel Krupa (2015) and Basu et al. (2017) which also included pae-
diatric patients. 55.1% of the patients were male and 44.9% female.
Of the total number of patients, 86% were in medical or surgical 
wards (oncology, orthopaedics, gastro, pulmonology, cardiology and 
internal medicine), and the remainder (14%) in intensive care units 
(ICUs).
The most frequently used tool to assess the incidence and se-
verity of phlebitis was the Visual Infusion Phlebitis (VIP) score, also 
known as the Jackson scale (n = 12). The modified VIP score was also 
applied (n = 5). The other 5 scales that were used were the Numeric 
Rating Scale (n = 1), the Infiltration Scale (n = 1), the Thrombophlebitis 
Scale (n = 1), the Standard Visual Rating Scale (n = 1) and the Visual 
Analogue Scale (VAS) The most assessed sign was pain through the 
VAS (n = 7). Other signs and symptoms of phlebitis that were as-
sessed included surrounding red swelling, hyperaemia, warmness, 
redness, tenderness and oedema.
4.3  |  Validity and methodological quality
Figure 2 shows the detailed assessment of the risk of bias for the 
papers included in this review. 50% present a low risk of bias in the 
generation of random sequences, though it should be noted that 
12 of the included studies were quasi- RCT and 2 pre- experimental. 
Allocation concealment (selection bias) only took place in three of 
the studies (Bigdeli Shamloo et al., 2019; Ghorbani et al., 2016; Selva 
Grace et al., 2020). A similar situation of uncertainty is found in the 
blinding of participants and personnel (performance bias), which is 
only described in 4 of the studies (Basu et al., 2017; Ghorbani et al., 
2016; Selva Grace et al., 2020; Sharma, 2016), and in the blinding of 
results assessment (detection bias), which is reported in just 3 stud-
ies (Basu et al., 2017; Bigdeli Shamloo et al., 2019; Selva Grace et al., 
2020). Reporting bias is high (63.6%), mainly due to insufficient data 
or the absence of a pre- specified protocol. In contrast, 63.6% of the 
cases are presented with full results data or the missing data do not 
have a sufficient effect for the study.
4.4  |  Findings of the review
The main findings in relation to the products, presentation, dosage, 
mode of application and their effectiveness are presented in Table 2.
The findings were classified into 3 groups: (1) Physical mea-
sures; (2) Phytotherapeutic treatments; and (3) Pharmacological 
treatments.
4.4.1  |  Physical measures
The physical measures reported in the studies were the applica-
tion of cold, warmth and heat. Three of the eight studies which 
included physical measures reported better results in terms of re-
gression of the phlebitis or hyperaemia: heat (Shilpa et al., 2015), 
F I G U R E  1  PRISMA 2009 flow 
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cold vs. glycerine and aloe vera (Yadav et al., 2016) and warmth vs. 
untreated (Hidayah et al., 2017). In the study by Rukhsana et al. 
(2016), cold and magnesium sulphate- glycerine were found to be 
equally effective.
As for the mode of administration, cold was applied through ice 
packs or compresses at <15°C (Jayabharathi, 2015; Rukhsana et al., 
2016; Sharma, 2016; Varghese & Moly, 2018), warmth through warm 
water compresses at 45°C (Hidayah et al., 2017; Jourabloo et al., 
2017), and heat also through compresses but without specifying the 
temperature (Shilpa et al., 2015). The treatments were applied for 
5– 20 min every 8 or 12 h during 2– 3 days.
4.4.2  |  Phytotherapeutic treatments
The potential of phytotherapeutic treatments was explored in 11 
of the studies included in this review in relation to the applica-
tion of phellodendron, quercetin, ichthammol glycerine, calendula, 
chamomile, sesame and aloe vera. A total of 8 studies reported 
an improvement in the phlebitis: calendula vs. application of 
warmth (Jourabloo et al., 2017), quercetin vs. eucerin (Ghorbani 
et al., 2016), phellodendron vs. magnesium sulphate (Wan, 2018) 
and ichthammol glycerine vs. heparinoids or magnesium sulphate- 
glycerine (Basu et al., 2017; Thomas et al., 2016). In the study by 
Soloman et al. (2015), ichthammol glycerine and heparinoids were 
found to be equally effective. Sesame was found to be effective 
for the control of pain only in comparison with massage (Bigdeli 
Shamloo et al., 2019) or alcohol compresses (Damanik, 2017). 
Other authors (Lila, 2017) highlighted the clinical value of chamo-
mile. Finally, aloe vera was the only phytotherapeutic product to 
be found less effective than the treatments they were compared 
with (Vidhya, 2017; Yadav et al., 2016).
The phytotherapeutic products were in the form of solution 
(phellodendron and ichthammol glycerine), oil (sesame and cham-
omile) and ointment (calendula, aloe vera and quercetin). The appli-
cation times varied considerably, from every 2 h to every 12 h and 
for 2– 7 days.
The solutions were applied with a compress and bandage. In the 
case of the phellodendron, the treatment was applied every 2 h for 
2 days and the limb was raised, wrapped in plastic and immobilised 
(Wan, 2018). The ichthammol glycerine was administered twice a 
day for 3 days (Thomas et al., 2016).
The oil- based treatments were applied by massage or using a 
compress. Chamomile (2.5 ml) was applied in a 10- min massage 3 
times a day for 3 days (Lila, 2017). The sesame treatment was applied 
(3 ml) in a 5- min massage twice a day for 7 days (Bigdeli Shamloo 
et al., 2019), or with a compress twice a day (Damanik, 2017).
Application of the ointment- based treatment was by massage 
and dressing. The calendula was applied by massage 3 times a 
day for 3 days (Jourabloo et al., 2017), the aloe vera with a gauze 
dressing twice a day for 2 days (Vidhya, 2017) and the quercetin 
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4.4.3  |  Pharmacological treatments
Pharmacological products were used in 13 studies. These were divided 
into three groups: anti- inflammatories (magnesium sulphate- glycerine, 
magnesium sulphate), antithrombotics (heparinoid) and moisturisers 
(glycerine).
Of the 9 studies which considered anti- inflammatories, 7 re-
ported an improvement in symptoms: magnesium sulphate- glycerine 
(Packialakshmi & Vidhya, 2017; Ravindra & Patel Krupa, 2015), vs. 
the application of cold (Varghese & Moly, 2018) and vs. heparinoids 
(Amuda et al., 2019; Jayabharathi, 2015; Selva Grace et al., 2020; 
Yambem et al., 2015). Magnesium sulphate without glycerine ob-
tained a better response than heparinoids and the application of cold 
(Sharma, 2016) and aloe vera (Vidhya, 2017). As for the antithrom-
botics, heparinoids were tested in 6 studies, but none obtained 
higher efficacy than the anti- inflammatories or phytotherapeutic 
products. Glycerine was only tested in one study, and its efficacy 
was found to be the same as that of aloe vera and lower than the 
application of cold (Yadav et al., 2016).
Concerning the mode of administration, some studies (Basu 
et al., 2017; Selva Grace et al., 2020; Soloman et al., 2015; Yadav 
et al., 2016; Yambem et al., 2015) provided no information In this 
respect, magnesium sulphate- glycerine was administered in solution 
form (Amuda et al., 2019; Packialakshmi & Vidhya, 2017; Varghese 
& Moly, 2018) through compress and bandage 2 or 3 times a day for 
2 or 3 days, in ointment form 3 times a day for 3 days (Jayabharathi, 
2015; Rukhsana et al., 2016), and with a bandage and raised limb 
twice a day for 2 days (Ravindra & Patel Krupa, 2015). Magnesium 
sulphate was applied every 2 h for 2 days in solution form with a com-
press, and the limb was raised, wrapped in plastic and immobilised 
(Wan, 2018), or it was applied in ointment form with a gauze dressing 
twice or 3 times a day for 2 or 3 days (Sharma, 2016; Vidhya, 2017).
The heparinoids were only administered as ointments (Amuda 
et al., 2019; Sharma, 2016; Yambem et al., 2015) by massage each 
8– 12 h for 2– 3 days, and a bandage (Thomas et al., 2016).
5  |  DISCUSSION
A total of 22 articles were analysed for this scoping review. Various 
topical treatments were identified for PVC- related phlebitis. The re-
sults obtained are discussed below in terms of: (1) Assessment of the 
phlebitis, (2) Products used and their efficacy; and (3) Pharmaceutical 
formulas and administration interventions.
5.1  |  Assessment of the phlebitis
The effectiveness of the treatments was determined on the basis of 
the signs and symptoms of the phlebitis and their evolution. It was 
found that no gold standard exists for the assessment of phlebitis. A 
total of 6 different scores/scales were found in the studies reviewed 
(VIP score, modified VIP score, Numeric Rating Scale, Infiltration 
Scale, Thrombophlebitis Scale and Standard Visual Rating Scale) and 
7 phlebitis- related signs and symptoms (pain, surrounding red swell-
ing, hyperaemia, warmness, redness, tenderness, oedema). This vari-
ety is at least partly due to the absence of universally accepted scales 
subjected to rigorous psychometric tests and validated for clinical 
F I G U R E  2  Risk of bias summary. *+: low risk, (−) high risk, (?) 
unclear risk
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use (Mihala et al., 2018). In this regard, Ray- Barruel et al. (2014) 
reported the existence of 71 phlebitis assessment scales which in-
cluded 15 different signs and symptoms, with the most common 
signs being erythema and pain. Consequently, there is a clear need 
for a consensus in relation to rigorous and validated instruments 
for the identification of PVC- related phlebitis to enable its optimal 
treatment and follow- up.
5.2  |  Products used and their efficacy
A wide variability was found in the topical products administered 
for the treatment of phlebitis. These were classified into physical 
measures, and phytotherapeutic and pharmacological treatments.
The physical measures differ considerably, primarily in their ap-
plication at different temperatures (cold, warm and hot). As in the 
present review, other studies support the use of warm compresses 
because of their vasodilating effect on the inflamed area (Annisa 
et al., 2017) or cold compresses to reduce the inflammation (Pérez 
Melgarejo, 2011). It is interesting to note that, according to the study 
by Gauttam and Vati (2016), both cold and warm compresses are 
equally effective against phlebitis (pain, erythema, induration and 
warmth). In this regard, it seems that the effect on the healing pro-
cess is more related to the compress and the wet environment than 
the temperature (Bryant & Nix, 2016). It should also be noted that 
the physical measures are much more economic and, given their non- 
pharmacological nature, adverse effects are non- existent (Hidayah 
et al., 2017). However, the results obtained show a very limited effi-
cacy. The studies included in this review undertook no comparisons 
(Hidayah et al., 2017; Shilpa et al., 2015) or were methodologically 
very poor (Yadav et al., 2016).
In relation to the phytotherapeutic treatments, the results of 
this review show their potential. Of the 11 selected studies, 8 re-
port regression of the phlebitis. The tested products were calendula 
(Jourabloo et al., 2017), quercetin (Ghorbani et al., 2016), phelloden-
dron (Wan, 2018), ichthammol glycerine (Basu et al., 2017; Thomas 
et al., 2016), sesame (Bigdeli Shamloo et al., 2019; Damanik, 2017) 
and chamomile (Lila, 2017). The results reported on the benefits of 
phytotherapeutic products concur with those of other studies and 
systematic reviews (Dos Reis et al., 2009; Gao et al., 2016; Goulart 
et al., 2020; Martín Gil et al., 2017). The efficacy of these products 
is due to their anti- inflammatory, anti- oxidant, anti- oedematous, 
anti- pyretic and anti- nociceptive properties (Bigdeli Shamloo et al., 
2019). The only product that reported a lower benefit than the prod-
ucts it was compared with was aloe vera (Vidhya, 2017; Yadav et al., 
2016), although this contradicts the results of other reviews (Zheng 
et al., 2014). However, it is important to note that studies performed 
with aloe vera (Gao et al., 2016; Zheng et al., 2014) assess the po-
tential of their effects (softening of blood vessels and restoration of 
blood vessel elasticity; improved lymphocyte activity and human im-
munity; dilation of blood vessels and promotion of blood circulation; 
antibacterial functions with contribution to the repair of damaged 
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are not conclusive and all of them recommend further, and more rig-
orous, studies. It is also important to bear in mind that many of the 
phytotherapeutic products are not marketed in western societies, 
which complicates their use (Higginson & Parry, 2011). Furthermore, 
a comparison of phytotherapeutic with pharmacological products is 
made more difficult by the fact that the latter products have been 
studied in greater depth and their efficacy has been more exten-
sively demonstrated (Goulart et al., 2020).
Magnesium sulphate is the most widely used pharmacological 
product, although the efficacy of this product is associated to its ap-
plication with glycerine. Magnesium sulphate contains magnesium, 
sulphur and oxygen that cleanses, moisturises the inflamed vein and 
reduces infection (Vidhya, 2017). While the glycerine improves the 
anti- inflammatory and hydrating properties as it avoids crystallisa-
tion of the layered structure of the stratum corneum, its hygroscopic 
property reduces loss of water from the skin (Kim et al., 2015). In 
addition, tolerance to glycerine is generally very high and adverse 
reactions are uncommon (Amuda et al., 2019).
Although heparinoids act at the epidermis level as anti- 
oedematous and decongestant agents with antiphlogistic and anti-
thrombotic properties (Amuda et al., 2019; Nader et al., 2004), their 
efficacy is limited against all the other products they were compared 
with in this review (magnesium sulphate- glycerine, magnesium 
sulphate and ichthammol glycerine). No study reported a greater 
benefit of heparinoids for the regression or control of PVC- related 
phlebitis, although a similar efficacy was obtained in the study by 
Soloman et al. (2015). The ambiguity of the results may be due to 
the fact that both products have an anti- inflammatory and analge-
sic effect, but the ichthammol glycerine is also antibacterial (Bakshi 
et al., 2018).
5.3  |  Pharmaceutical formulas and administration 
interventions
The treatments analysed in this review are wide- ranging in terms 
of their pharmaceutical formulas and administration (dosage, mode 
and frequency).
The most commonly used formula is ointment followed by solu-
tion and oil. However, the variety of treatments used does not allow 
an analysis by formula and product. For example, magnesium sul-
phate with and without glycerine was equally effective in solution 
or ointment form. No study compared the same product in different 
formulas. While both ointment and solution, the two most frequently 
used formulas, were found to be effective, in the studies by Bagheri- 
Nesami et al. (2014) and D’souza (2016) it is reported that the same 
product applied in ointment form has a greater efficacy than if ap-
plied in solution form. The fundamental difference between solution 
and ointment formulas lies in the different proportions of the oil and 
water that they contain. Ointments have a higher concentration of 
oil and are more greasy and emollient. The drawbacks of solution 
formulas include rapid evaporation of the water/alcohol, which influ-
ences the dissemination of the product and can result in an uneven 
topical dose in the treated area. In contrast, ointment is more uni-
formly distributed and is therefore a more appropriate formulation. 
In addition, the more oil there is and more greasy the product, the 
slower will be its absorption, and an ointment will therefore always 
remain on the skin for a longer time (Ivens et al., 2001).
With regard to the application of the product, massage or rub-
bing can increase the possibility of absorption (Sellarès Casas, 2013). 
In the study by Bigdeli Shamloo et al., (2019), it is highlighted that 
application of the product by a nursing professional with expertise 
in massage can increase its efficacy. Once the product has been 
applied, the placement of a bandage generates a certain amount 
of controversy in the consulted literature. On the one hand, the 
use of a bandage does not impede evaporation of the product nor 
does it improve its effectiveness (Lian et al., 2017), while on the 
other occlusion of the area increases the absorption of the product 
(Sellarès Casas, 2013) and keeps the skin moist. In this review, use 
of a bandage (sterile or gauze dressing) together with the product 
was found to be effective in a total of 9 studies (Amuda et al., 2019; 
Bigdeli Shamloo et al., 2019; Ghorbani et al., 2016; Jayabharathi, 
2015; Packialakshmi & Vidhya, 2017; Ravindra & Patel Krupa, 2015; 
Sharma, 2016; Thomas et al., 2016; Wan, 2018).
The most frequent time of application in the selected studies is 
3 days (17 products), while the minimum period is 2 days (8 products) 
and the longest is 7 days (1 product). The product is applied 2 or 3 
times daily. In concurrence with Goulart et al. (2020), the length of 
time and frequency of application is attributable more to the viabil-
ity of the study than to the substance that is being evaluated.
It should also be noted that the vast majority of the studies in-
cluded in this review do not consider any adverse effects resulting 
from application of the product. It would therefore be of great inter-
est to analyse this question in greater depth in order to assess the 
risk- benefit of the proposed interventions.
5.4  |  Limitations of the review
In relation to the limitations of this review, one of the inclusion cri-
teria was that the articles had to be written in English or Spanish 
to facilitate their interpretation. This criterion could have resulted 
in valid information being missed if the articles on topical treat-
ments of phlebitis had only been published in Chinese or other Asian 
languages.
All the studies included in this review are Asian in origin, sug-
gesting that further research in other national and international con-
texts is required to allow comparisons and reach a general consensus 
on treatments.
6  |  CONCLUSIONS
This scoping review evidences areas in the treatment of PVC- related 
phlebitis that require further research and studies with greater 
methodological rigour. The topical treatments analysed in this 
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review were divided into physical measures and pharmacological 
and phytotherapeutic treatments. The high number of treatments 
used and the considerable differences in their application make any 
comparison difficult. The physical measures are cheap and easy to 
apply, but their efficacy is limited. While the phytosanitary products 
display good research potential, their use and marketing in western 
culture is limited. Finally, of the pharmacological products the mag-
nesium sulphate (both with and without glycerine) gave better re-
sults than products such as heparinoids.
The most commonly used pharmaceutical formula is ointment, 
followed by solution and then oil. Massage and bandaging are ac-
tions related to the application of the products that enhance their 
absorption. However, the results do not allow the establishment of 
any clear evidence as to which product to use or how to use it.
7  |  RELE VANCE TO CLINIC AL PR AC TICE
The variability of the products and their form of presentation for 
the treatment of PVC- related phlebitis shows heterogeneity in its 
assessment. The summary of the information offered in this scoping 
review in relation to the nature of the treatments, the pharmacologi-
cal presentation, the mode of application and their effect in relation 
to the regression of the degree of phlebitis is a clinical decision aid 
for nurses in clinical practice. Furthermore, these results encour-
age them to deliberate on the basis of the evidence that is avail-
able, about the treatments that are administered in accordance with 
healthcare quality and patient safety. Basing decisions on evidence 
helps reduce errors, provides comfort to patients, avoids secondary 
complications and optimises economic resources.
Based on the above, magnesium sulphate either with or with-
out glycerine is postulated as the most effective treatment for PVC- 
related phlebitis. However, there are products used in Asian regions 
that have not been tested in the Western context, so it is difficult 
to conclude which product is best. More evidence needs to be gen-
erated in different national and international contexts in order to 
foster a consensus with respect to the different products that are 
available and their application. Further progress in this respect is 
vital, as the assessment and treatment of this type of phlebitis is a 
responsibility that corresponds to the nurse. To know the applicabil-
ity, costs, availability and evidence of these products will determine 
best practices.
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